Isoform selective inhibition and inactivation of human cytochrome P450s by methylenedioxyphenyl compounds

References

• CARRIERE, V., GOASDUFF, T., RATANASAVANH, D., MOREL, F., GAUTIER, J.-C., GUILLOUZ0, A., BEAUNE, P. and BERTHOU, F., 1993, Both cytochrome P450 2E1 and 1A1 are involved in the metabolism of chlorzoxazone. Chemical Research in Toxicology, 6, 852–857.
   Google Scholar
• CAsrDA, J. E., 1970, Mixed function oxidase involvement in the biochemistry of insecticide synergists. Journal of Agricultural and Food Chemistry, 18,753–772.
   PubMedGoogle Scholar
• CHIBA, K., KOBAYASHI, K., MANABE, K., TANI, M., KAMATAKI, T. and IsHizmu, T., 1993, Odative metabolism of omeprazole in human liver microsomes : cosegregation with S-mephenytoin hydroxylation. Journal of Pharmacology and Experimental Therapeutics, 266, 52–59.
   PubMed Web of Science ®Google Scholar
• CHIBA, M., NISHIME, J. A. and LrN, J. H., 1995, Potent and selective inactivation of human liver microsomal cytochrome P-450 isoforms by L-754,394, an investigational human immune deficiency virus protease inhibitor. Journal of Pharmacology and Experimental Therapeutics, 275, 1527–1534.
   PubMed Web of Science ®Google Scholar
• DAHL, A. R. and HODGSON, E., 1979, The interaction of aliphatic analogs of methylenedioxyphenyl compounds with cytochromes P-450 and P-420. Chemico-Biological Interactions, 27, 163–175.
   PubMed Web of Science ®Google Scholar
• EKINS S., VANDENBRANDEN, M., RING, B. J., GILLESPIE, J. S., YANG, T. J., GELBOIN, H. V. and WIUGHTON S. A., 1998, Further characterization of the expression in liver and catalytic activity of CYP2B6.1ourna/ of Pharmacology and Experimental Therapeutics, 286, 1253–1259.
   Google Scholar
• ELCOMBE C. R., BRIDGES, J. W., Nimmo -SmiTH, R. H. and WERIUNGLOER, J., 1975, Cumene hydro-peroxide-mediated formation of inhibited complexes of methylenedioxyphenyl compounds with cytochrome P-450. Biochemical Society Transactions, 3, 967–970.
   Google Scholar
• EUGSTER, H.-P., PROBST, M., WIJRGLER, F. E. and SENGSTAG C., 1993, Caffeine, estradiol, and progesterone interact with human CYP1A1 and CYP1A2. Evidence from cDNA-directed expression in Saccharomyces cerevisiae. Drug Metabolism and Disposition, 21, 43–49.
   PubMed Web of Science ®Google Scholar
• FRANKLIN, M. R., 1971, The enzymic function of a methylene dioxyphenyl derivative exhibiting an isocyanide-like spectrum with reduced cytochrome P-450 in hepatic microsomes. Xenobiotica, 1, 581–591.
   PubMedGoogle Scholar
• GUENGFRICH, F. P., 1990, Mechanism-based inactivation of human liver microsomal cytochrome P-450 111A4 by gestodene. Chemical Research in Toxicology, 3, 363–371.
   PubMedGoogle Scholar
• GUENGERICH, F. P., 1992, Characterization of human cytochrome P-450 enzymes. FASEB Journal, 6, 745–748.
   PubMed Web of Science ®Google Scholar
• HANSCH, C., 1968, The use of homolytic, steric, and hydrophobic constants in a structure-activity study of 1,3-benzodioxole synergists. Journal of Medicinal Chemistry, 11, 920–924.
   PubMed Web of Science ®Google Scholar
• HENNESSY, D. J. 1965, Hydride-transferring ability of methylenedioxybenzenes as a basis of synergistic activity. Journal of Agricultural and Food Chemistry, 13, 218–220.
   Web of Science ®Google Scholar
• HODGSON, E. and PHILPOT, R. M., 1974, Interaction of methylene dioxyphenol (1,3-benzodioxole) compounds with enzymes and their effects on mammals. Drug Metabolism Reviews, 3, 231–301.
   PubMed Web of Science ®Google Scholar
• HODGSON, E., PHILPOT, R. M., BAKER, R. C. and MAILMAN, R. B., 1973, Effects of synergist on drug metabolism. Drug Metabolism and Disposition, 1, 391–401.
   PubMed Web of Science ®Google Scholar
• IOANNLDES, C., DELAFORGE, M. and PARKE, D. V., 1981, Safrole: its metabolism, carcinogenicity and interactions with cytochrome P-450. Food and Cosmetics Toxicology, 19, 657–666.
   PubMedGoogle Scholar
• KAMIENSKY, F. X. and MURPHY, S. D., 1971, Biphasic effects of methylenedioxyphenyl synergists on the action of hexobarbital and organophosphaik insecticides in mice. Toxicology and Applied Pharmacology, 18, 883–894.
   PubMedGoogle Scholar
• KAMINSKY, L. S. and ZHANG, Z.-Y., 1997, Human P450 metabolism of warfarin. Pharmacology and Therapeutics, 73, 67–74.
   Google Scholar
• KRONBACH, T., MATHYS, D., GUT, J., CATIN, T. and MEYER, U. A., 1987, High-performance liquid chromatographic assays for bufuralol 1'-hydroxylase, debrisoquine 4-hydroxylase, and dextro-methorphan 0-demethylase in microsomes and purified cytochrome P-450 isozymes of human liver. Analytical Biochemistry, 162, 24–32.
   PubMedGoogle Scholar
• KUNZE, K. L. and TRAGER, W. F., 1993, Isoform-selective mechanism-based inhibition of human cytochrome P-4501A2 by furafylline. Chemical Research in Toxicology, 6, 649–656.
   PubMed Web of Science ®Google Scholar
• MANSUY, D., BATTION, J. P., CHOTTARD, J. C. and ULLRICH, V., 1979, Preparation of a porphyrin iron carbene model for cytochrome P-450 complexes obtained upon metabolic activation of the insecticide synergists of the 1,3-benzodioxole series. Journal of the American Chemical Society, 101, 3971–3972.
   Web of Science ®Google Scholar
• MURRAY, M., WILKINSON, C. F. and DUBE, C. E., 1983a, Effects of dihydrosafrole on cytochrome P-450 and drug oxidation in hepatic microsomes from control and induced rats. Toxicology and Applied Pharmacology, 68, 66–76.
   PubMed Web of Science ®Google Scholar
• MURRAY, M., WILKINSON, C. F., MARCUS, C. and DUBE, C. E., 1983b, Structure-activity relationships in the interactions of alkoxymethylenedioxybenzene derivatives with rat hepatic microsomal mixed-function oxidases in vivo. Molecular Pharmacology, 24, 129–136.
   PubMed Web of Science ®Google Scholar
• MURRAY, M., HETNARSKI, K. and WILKINSON, C. F., 1985, Selective inhibitory interactions of alkoxymethylenedioxybenzenes towards mono-oxygenase activity in rat-hepatic microsomes. Xenobiotica, 15, 369–379.
   PubMed Web of Science ®Google Scholar
• NAKAJIMA M., OHYAMA, K., NAKAMURA, S., SHEVIADA, N., YAMAZAKI, H. and Yoxoi, T., 1999, Inhibitory effects of azelastine and its metabolites on drug oxidation catalyzed by human cytochrome P450 enzymes. Drug Metabolism and Disposition, 27, 792–797.
   Google Scholar
• NELSON, D. R., KOYMANS, L., KAMATAKI, T., STEGEMAN, J. J., FEYEREISEN, R., WAXIVIAN, D. J., WATERMAN, M. R., GOTOH, 0., COON, M. J., ESTABROOK, R. W., GUNSALUS, I. C. and NEBERT D. W., 1996, P450 superfamily; update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics, 6, 1–42.
   Google Scholar
• RENDIC S. and DI CARLO, F. J., 1997, Human cytochrome P450 enzymes: a status report summarizing their reactions, substrate, inducers, and inhibitor Drug Metabolism Reviews, 29, 413–580.
   Google Scholar
• SILVERMAN, R. B., 1988, Mechanism-based enzyme inactivation. In Chemistry and Enzymology (Boca Raton: CRC Press), Vols 1 and 2, pp. 3–16.
   Google Scholar
• SPATZENEGGER, M. and JAEGER, W., 1995, Clinical importance of hepatic cytochrome P450 in drug metabolism. Drug Metabolism Review, 27, 397–417.
   PubMed Web of Science ®Google Scholar
• ULLRICH, V. and SCHNABEL, K. H., 1973, Formation and ligand binding of the fluorenyl carbanion by hepatic cytochrome P-450. Archives of Biochemistry and Biophysics, 159, 240–248.
   PubMed Web of Science ®Google Scholar
• WALEY S. G., 1985, Kinetics of suicide substrates. Practical procedures for determining parameters. Biochemical Journal, 227, 843–849.
   PubMed Web of Science ®Google Scholar
• WAXMAN, D. J., ATTISANO, C., GUENGERICH, F. P. and LAPENSON, D. P., 1988, Human liver microsomal steroid metabolism: identification of the major microsomal steroid hormone 6/3-hydroxylase cytochrome P-450 enzyme. Archives of Biochemistry and Biophysics, 263, 424–436.
   PubMed Web of Science ®Google Scholar
• WILKINSON, C. F., MURRAY, M. and MARCUS, C. B., 1984, Interaction of methylenedioxyphenyl compounds with cytochrome P-450 and effects on microsomal oxidation. In Reviews in Biochemical Toxicology, edited by E. Hodgson, J. R. Bend and R. M. Philpot (Amsterdam: Elsevier), 6, pp. 27–63.
   Google Scholar
• YAMAZAKI, H., Guo, Z. and GUENGERICH, F. P., 1995, Selectivity of cytochrome P4502E1 in chlorzoxazone 6-hydroxylation. Drug Metabolism and Disposition, 23, 438–440.
   PubMed Web of Science ®Google Scholar
• YUN, C.-H., SHEVIADA, T. and GUENGERICH, F. P., 1991, Purification and characterization of human liver microsomal cytochrome P-4502A6. Molecular Pharmacology, 40, 679–685.
   PubMed Web of Science ®Google Scholar